Description
The purpose of this study is to characterize participants in the BE WELL trial of a life-style modification, weight loss intervention trial in patients with poorly controlled asthma in terms of their atopy phenotype and serum periostin and 8-isoprostane levels in exhaled breath condensate at baseline and follow-up, and to maintain and utilize the BE WELL serum bank for the purpose of better understanding the relation between asthma control and both obesity and weight loss.
Co-Investigators/Collaborators: John Matthews, MBBS, MRCP, PhD, and Cecile Holweg, PhD, Genentech; Carlos Camargo, Jr., MD, Dr PH, Massachusetts General Hospital and Harvard Medical School; Anne Dixon, MA, BM, BCh, University of Vermont Lung Center and College of Medicine; Sally Wenzel, MD, University of Pittsburgh Asthma Institute and School of Medicine.
Co-Investigators/Collaborators: John Matthews, MBBS, MRCP, PhD, and Cecile Holweg, PhD, Genentech; Carlos Camargo, Jr., MD, Dr PH, Massachusetts General Hospital and Harvard Medical School; Anne Dixon, MA, BM, BCh, University of Vermont Lung Center and College of Medicine; Sally Wenzel, MD, University of Pittsburgh Asthma Institute and School of Medicine.
Funder
Sutter Health and Palo Alto Medical Foundation
Research Topics
Related Studies
Measurement of Quality of Life and Perceived Disease Impact on Quality of Life in Asthma
Purpose is to evaluate the properties of a new measure of the pt-perceived effects of asthma in adults, A-IQOLS, and compare with those of the Flanagan QOLS.
Can diet- and exercise-induced weight loss improve asthma control in obese adults?
This trial investigates the efficacy of a state-of-the-art behavioral weight loss intervention in improving asthma control for obese adult patients.
A Pilot Study of the DASH Diet in Not-Well-Controlled Adult Asthma
This study evaluates the feasibility and potential efficacy of adopting the DASH eating pattern to improve asthma control among adults with uncontrolled asthma.